Clinical end points for the assessment of cytostatic agents.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D014408:Biomarkers, Tumor / Q000032:analysis; D002986:Clinical Trials as Topic; D023381:Endpoint Determination; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D011379:Prognosis; D012107:Research Design; D013534:Survival
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor